Objective to explore the risk factors and the forecasting nursing methods of pulmonary thrombosis and embolism (PTE).

目的探讨肺血栓塞症(pte)危险因素和预见性的护理措施。

youdao

Increases the risk of deep vein thrombosis, pulmonary embolism, heart attack, stroke and cervical cancer.

增加静脉血栓形成，肺栓塞，心脏病，中风和宫颈癌的风险。

youdao

The two most common manifestations of VTE are deep vein thrombosis and pulmonary embolism.

静脉血栓栓塞的两种最常见表现是深静脉血栓形成和肺栓塞。

youdao

Rivaroxaban is currently indicated in the US for stroke reduction in patients with atrial fibrillation, for the treatment and prevention of recurrence of deep venous thrombosis and pulmonary embolism, and for DVT prophylaxis after orthopedic surgery.

FORBES: Xarelto Effective In Medically Ill Patients But At High Bleeding Cost

The U.S. Food and Drug Administration today expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE following initial treatment.

FORBES: Rivaroxaban Gains FDA Indications For The Treatment And Prevention Of DVT And PE